Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity. Andersen MD, Wolter K, Enemark MH, Lauridsen KL, et al. Leuk Lymphoma 2024 Dec 3:1-12. doi: 10.1080/10428194.2024.2434170.

Read + Share

Amedeo Smart

Independent Medical Education

Andersen MD, Wolter K, Enemark MH, Lauridsen KL, et al. Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity. Leuk Lymphoma 2024 Dec 3:1-12. doi: 10.1080/10428194.2024.2434170.
PMID: 39625996